Sandoz confirms European Commission nod of Pyzchiva Ruchika Sharma23 April 2024 11:54 AM ISTBasel: Sandoz has announced that the European Commission (EC) has granted marketing authorization for Pyzchiva (biosimilar ustekinumab) developed...
Fire acupuncture may control symptoms and prevent recurrence in patients with psoriasis: Study Dr. Shravani Dali23 April 2024 8:45 AM ISTFire acupuncture may significantly control symptoms and prevent recurrence in patients with psoriasis suggests a study published in the Medicine.A...
Desloratadine addition to isotretinoin regimen reduces pruritus in acne and improves patient satisfaction: AIIMS research Medha Baranwal21 April 2024 8:45 PM ISTIndia: A recent study published in the International Journal of Dermatology has suggested the role of desloratadine, added to an isotretinoin regimen,...
Non-invasive light-based techniques may improve detection of skin cancer, reveals study Dr. Kamal Kant Kohli19 April 2024 10:00 PM ISTA study conducted by Aston University researchers has demonstrated that the appearance of ageing skin looks noticeably different compared to younger...
Oral minoxidil vs topical minoxidil: Choosing the right treatment for male androgenetic alopecia Medha Baranwal18 April 2024 11:15 PM ISTBrazil: For treating men with androgenetic alopecia (AGA), low-dose low-dose oral minoxidil (5 mg per day) has similar efficacy to topical minoxidil,...
Erenumab: A Potential Breakthrough in Rosacea Management Medha Baranwal18 April 2024 9:00 AM ISTDenmark: A nonrandomized controlled trial showed the importance of the calcitonin gene-related peptide (CGRP) pathway in the pathophysiology of...
Unlocking Insights: The real-world BrIDGE study on brodalumab effectiveness in psoriasis patients Medha Baranwal17 April 2024 7:45 AM ISTGreece: A large-scale study evaluating brodalumab for moderate-to-severe plaque psoriasis revealed significant improvements in patient outcomes.The...
Elevated calcitonin gene-related peptide levels linked to rosacea: A Groundbreaking Study Medha Baranwal15 April 2024 8:00 PM ISTDenmark: A recent study published in the Journal of the European Academy of Dermatology and Venereology has revealed significantly higher calcitonin...
Study compares patch test positivity: 24 versus 48 hours of occlusion time in allergic contact dermatitis patients Medha Baranwal12 April 2024 7:30 AM ISTIndia: A recent prospective study published in Contact Dermatitis compared patch test positivity after 24 and 48 hours of occlusion time in patients...
Rilzabrutinib therapy in pemphigus patients shows effective outcomes in phase 2 trial Jacinthlyn Sylvia11 April 2024 8:00 AM ISTA recent phase 2 clinical trial found positive outcomes in patients with pemphigus a rare and potentially life-threatening autoimmune disease. The...
Lupin unveils first generic version of Oracea in US Ruchika Sharma10 April 2024 11:15 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of first generic version of Oracea (Doxycycline Capsules, 40 mg), in the...
Adjuvant HBOT is beneficial in treating patients with pyoderma gangrenosum: Study Medha Baranwal10 April 2024 9:00 AM ISTBrazil: A recent study has revealed that adjuvant hyperbaric oxygen therapy (HBOT) may provide some benefits in treating pyoderma gangrenosum...
